Coverage
-
April 05, 2013
A New Jersey federal judge approved a final settlement Thursday in Sunovion Pharmaceuticals Inc.'s patent infringement suit against Sun Pharma Global Inc. over its sleep aid drug Lunesta, a deal that bars Sun Pharma from making or selling a generic version of Lunesta before April 2014.
2 other articles on this case.
View all »